Preliminary Program

All presentations will take place at the Hilton West Palm Beach in Oceana Ballroom B-D.

 

7:00am - 9:00am
Registration 

8:00am - 8:10am
Welcome

 

8:10am - 11:40am

Session I: Viral Diagnostics in Transplant Recipients and Immunocompromised Hosts   
Time includes detailed, interactive case presentation with discussion by panel members and audience.

 

Moderators: 

Randall T. Hayden, M.D.; St. Jude Children's Research Hospital, Memphis, TN 
Matthew J. Binnicker, Ph.D., D(ABMM); Mayo Clinic, Rochester, MN 

 

8:10am - 9:40am
Instructional Cases
Kimberly Hanson, M.D., MHS; University of Utah and ARUP Laboratories, Salt Lake City, UT
Michael G. Ison, M.D.; Northwestern University, Chicago, IL
Jutta Preiksaitis, M.D.; University of Alberta, Edmonton, Canada

 

9:40am - 10:00am 

Break

 

10:00am - 11:40am

Instructional Cases
Kimberly Hanson, M.D., MHS; University of Utah and ARUP Laboratories, Salt Lake City, UT

Michael G. Ison, M.D.; Northwestern University, Chicago, IL

Jutta Preiksaitis, M.D.; University of Alberta, Edmonton, Canada


11:30am - 11:45am

Break

 

11:45am -3:45pm

Session II: Technology Update

 

Moderator: 

Melissa B. Miller, Ph.D., D(ABMM); University of North Carolina School of Medicine, Chapel Hill, NC

 

11:45am - 12:15pm

Digital PCR
Jim Huggett, BSc, Ph.D., FRCP (Edin); LGC, Teddington, United Kingdom

 

12:15pm - 12:30pm

Discussion

 

12:30pm - 1:30pm
Lunch

 

1:30pm - 2:00pm

Amplification Chemistries
Sherry Dunbar, Ph.D., MBA; Luminex Corporation, Austin, TX

 

2:00pm - 2:15pm

Discussion


2:15pm - 2:45pm

Primer/Probe Design
Russ Higuchi, Ph.D.; Cepheid, Sunnyvale, CA

 

2:45pm - 3:00pm
Discussion

 

3:00pm - 3:30pm

PCR Enzymes: What’s the Difference?

Mark Poritz, Ph.D.; BioFire Defense, Salt Lake City, UT

 

3:30pm - 3:45pm

Discussion/Wrap-Up

 

This one-day interactive workshop focuses on practical aspects of molecular diagnostics and on exciting new technologies. This year’s sessions encompass instructive and interactive case presentations to illustrate key principles of clinical diagnostic molecular virology, together with in-depth technical discussions on digital PCR, primer-probe design, amplification chemistries and enzymes.

 

Upon completion of the activity, participants should be better able to:
- Apply clinical molecular virologic testing and the results of that testing to the care of immunocompromised patients.
- Discuss the importance of standardizing testing and result interpretation.
- Explain the principles of digital PCR and its potential applications to clinical virology
- Describe technical elements of PCR and other molecular amplification chemistries, including primer-probe design and the use of different enzymes
- Apply clinical molecular virologic testing and the results of that testing to the care of immunocompromised patients.

Level: Intermediate                  

 

Association Management Software Powered by YourMembership  ::  Legal